1  Introduction to Clinical Trials

1.1 Introduction

Clinical trials refer to systematic research studies conducted to evaluate the safety and efficacy of drug compounds in humans. While drug development begins with pre-clinical studies in laboratories and animals, this book focuses exclusively on human clinical trials. Clinical trials are conducted in sequential phases, including Phase I, Phase II, Phase III, and Phase IV. Each phase serves a distinct purpose in assessing a drug’s safety profile, dosage, effectiveness, and long-term outcomes. Once the drug has gone through all the necessary phases of developed and the results confirm that indeed the drug compared is both safe and effective in treating the condition being studied, the regulatory bodies give their final approval and the drug is made available to the general public. There are two major regulatory bodies that oversee all the aspects of clinical trial experiments, these bodies are: Food and Drug Administration (FDA) based in USA and Pharmaceuticals and Medical Devices Agency (PMDA) which regulates clinical trials conducted in Japan.

This book emphasizes the role of statistical programming in supporting clinical trials, with a primary focus on the R programming language. R will be used to process, analyze, and report clinical trial data, particularly for generating outputs aligned with CDISC standards such as SDTM (Study Data Tabulation Model), ADaM (Analysis Data Model), and TLFs (Tables, Listings, and Figures). The book aims to bridge statistical concepts and practical programming workflows used in real-world clinical research settings.

1.1.1 Pre-clinical phase

This phase is usually conducted in animals to observe the toxicity levels and safety of the drug compound before human clinical trials are conducted.

1.1.2 Phase I trials

This is the first study done with human subjects. Its usually carried out on healthy volunteers or individuals with the condition under study. It involves a small number of participants, roughly 10 to 100. The main objectives include to determine safety and dosing levels of the new drug compound.

1.1.3 Phase II trials

At this stage, the experiments advances in terms of measuring safety and also early assessment of efficacy is done at this phase. Participants in the clinical trial at this phase typically involves individuals suffering from the condition that is to be treated by the new proposed therapy. The number of individuals involved is about 100 to 300.

1.1.4 Phase III trials

This a relatively larger trial as compared to phase I and phase II and its objectives are to further confirm the safety profile and efficacy of the new drug compound to a larger population. The number of participants involved is usually 300 to 3000. After this phase of the study if the safety and efficacy profiles are confirmed to be superior as compared to placebo or the current standard-of-care, the drug compound is approved by the regulatory bodies to be officially sold in the market.

1.1.5 Phase IV/ Real World Trials

This phase is not usually conducted for every proposed drug therapy. This phase is usually done after the drug has been approved and is available to general public. The objective is to evaluate long term safety and efficacy and to monitor any real world side effects.

1.2 CDISC Standards

CDISC stands for Clinical Data Interchange Standards Consortium. CDISC has developed a number of standard data set models but we will only focus on two which are common, i.e SDTM and ADAM standards. These standards are using in organizing raw clinical data in well structured formats to enable advanced analysis. They offer general guidance into how raw data should be organized into various topics of interest in clinical research.

1.3 Study Documents

Statistical programming relies on several key study documents that provide essential context and guidance for working with clinical trial data. These documents help programmers understand the study design, data structure, and analysis requirements.

Commonly referenced documents include the Case Report Forms (CRFs), Study Protocol, Statistical Analysis Plan (SAP), Study Specifications, and Tables, Listings and Figures (TLF) shells, SDTM Implementation Guide, ADAM Implementation guide among others. It is strongly recommended that programmers thoroughly review and understand these documents before beginning any programming tasks.